Literature DB >> 1948070

Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.

D L Scott1, S P White, J L Browning, J J Rosa, M H Gelb, P B Sigler.   

Abstract

Phospholipase A2 (PLA2) participates in a wide range of cellular processes including inflammation and transmembrane signaling. A human nonpancreatic secretory PLA2 (hnps-PLA2) has been identified that is found in high concentrations in the synovial fluid of patients with rheumatoid arthritis and in the plasma of patients with septic shock. This enzyme is secreted from certain cell types in response to the proinflammatory cytokines, tumor necrosis factor or interleukin-1. The crystal structures of the calcium-bound form of this enzyme have been determined at physiological pH both in the presence [2.1 angstrom (A) resolution] and absence (2.2 A resolution) of a transition-state analogue. Although the critical features that suggest the chemistry of catalysis are identical to those inferred from the crystal structures of other extracellular PLA2s, the shape of the hydrophobic channel of hnps-PLA2 is uniquely modulated by substrate binding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1948070     DOI: 10.1126/science.1948070

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  38 in total

1.  Total chemical synthesis of enzymatically active human type II secretory phospholipase A2.

Authors:  T M Hackeng; C M Mounier; C Bon; P E Dawson; J H Griffin; S B Kent
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  The molecular basis of phosphatidylcholine preference of human group-V phospholipase A2.

Authors:  K P Kim; S K Han; M Hong; W Cho
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

3.  Sterol and steryl ester regulation of phospholipase A2 from the mosquito parasite Lagenidium giganteum.

Authors:  J L Kerwin; J K MacKichan; M J Semon; A M Wiens; C C DeRose; J J Torvik
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

4.  Crystal structure of the complex formed between a group I phospholipase A2 and a naturally occurring fatty acid at 2.7 A resolution.

Authors:  Garima Singh; Jayasankar Jasti; K Saravanan; Sujata Sharma; Punit Kaur; A Srinivasan; Tej P Singh
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

5.  Atomic resolution structure of the double mutant (K53,56M) of bovine pancreatic phospholipase A2.

Authors:  K Sekar; M Yogavel; D Gayathri; D Velmurugan; R Krishna; M-J Poi; Z Dauter; M Dauter; M-D Tsai
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-12-16

6.  Chemical modification and inactivation of phospholipases A2 by a manoalide analogue.

Authors:  S Fujii; Y Tahara; M Toyomoto; S Hada; H Nishimura; S Inoue; K Ikeda; Y Inagaki; S Katsumura; Y Samejima
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

7.  Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.

Authors:  Caitlin E Cassidy; William N Setzer
Journal:  J Mol Model       Date:  2009-07-15       Impact factor: 1.810

8.  Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.

Authors:  Lars Linderoth; Thomas L Andresen; Kent Jørgensen; Robert Madsen; Günther H Peters
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

9.  Lipid-binding proteins: structure of the phospholipid ligands.

Authors:  Derek Marsh
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

10.  Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue.

Authors:  S Andersen; W Sjursen; A Laegreid; G Volden; B Johansen
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.